Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 2/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30420527 | 1.00 | PRSS1 (0.53) | PRSS1PRSS2PRSS3TSHRCNR2 | |
| SCHEMBL5991861 | 0.82 | TP53 (0.48) | PRSS1PRSS2PRSS3CNR2MEN1 | |
| SCHEMBL27140587 | 0.82 | TRPA1 (0.48) | PRSS1PRSS2PRSS3TSHRMEN1 | |
| SCHEMBL28151612 | 0.82 | LOXL2 (0.56) | PRSS1PRSS2PRSS3TSHRENPP2 | |
| SCHEMBL814654 | 0.80 | MEN1 (0.52) | TSHRMEN1KMT2AMAPTHTT | |
| SCHEMBL12802141 | 0.79 | KAT6A (0.49) | PRSS1PRSS2PRSS3CNR2MEN1 | |
| SCHEMBL21811989 | 0.78 | MEN1 (0.50) | TSHRMEN1KMT2AMAPTHTT | |
| SCHEMBL28804284 | 0.78 | F10 (0.43) | MEN1KMT2ASMN1; SMN2NPC1TP53 | |
| SCHEMBL609571 | 0.78 | ALDH1A1 (0.53) | TSHRMEN1KMT2AGRM2 | |
| SCHEMBL16105770 | 0.78 | FOLH1 (0.42) | MEN1KMT2AFOLH1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4430097-B1 | NEUTRAL BRUSHES WITH TUNABLE POLARITY FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS WITH POLY(STYRENE) AND POLY(METHYL METHACRYLATE) CONTAINING SEGMENTS | MERCK PATENT GMBH (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-20250244671-A1 | NEUTRAL BRUSHES WITH TUNABLE POLARITY FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS WITH POLY(STYRENE) AND POLY (METHYL METHACRYLATE) CONTAINING SEGMENTS | EMD PERFORMANCE MATERIALS CORP. | 2025-07-31 | — | — | US | disclosed |
| WO-2023083933-A1 | NEUTRAL BRUSHES WITH TUNABLE POLARITY FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS WITH POLY(STYRENE) AND POLY(METHYL METHACRYLATE) CONTAINING SEGMENTS | MERCK PATENT GMBH (DE) | 2023-05-19 | — | — | WO | disclosed |
| CN-110114377-B | Novel compositions and methods for block copolymer self-assembly | 默克专利有限公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-3858872-B1 | COMPOSITIONS AND PROCESSES FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS | MERCK PATENT GMBH (DE) | 2022-05-11 | — | — | EP | disclosed |
| EP-3559053-B1 | COMPOSITIONS AND PROCESSES FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS | MERCK PATENT GMBH (DE) | 2022-04-13 | — | — | EP | disclosed |
| EP-3858872-A1 | NOVEL COMPOSITIONS AND PROCESSES FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS | Merck Patent GmbH (DE) | 2021-08-04 | — | — | EP | disclosed |
| US-11067893-B2 | Compositions and processes for self-assembly of block copolymers | MERCK PATENT GMBH (DE) | 2021-07-20 | — | — | US | disclosed |
| EP-3559053-A1 | NOVEL COMPOSITIONS AND PROCESSES FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS | Ridgefield Acquisition (LU) | 2019-10-30 | — | — | EP | disclosed |
| WO-2018114930-A1 | NOVEL COMPOSITIONS AND PROCESSES FOR SELF-ASSEMBLY OF BLOCK COPOLYMERS | AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) | 2018-06-28 | — | — | WO | disclosed |
| EP-2385032-A1 | GPR40 Receptor function regulator | Takeda Pharmaceutical Company Limited (JP) | 2011-11-09 | — | — | EP | disclosed |
| US-7960369-B2 | Receptor function regulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20090012093-A1 | Receptor Function Regulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-01-08 | — | — | US | disclosed |
| CN-1735408-A | Receptor function controlling agent | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2006-02-15 | — | — | CN | disclosed |
| EP-1559422-A1 | RECEPTOR FUNCTION CONTROLLING AGENT | Takeda Pharmaceutical Company Limited (JP) | 2005-08-03 | — | — | EP | disclosed |
| EP-0533695-B1 | IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY | PFIZER (US) | 1994-10-05 | — | — | EP | disclosed |
| US-5322847-A | Inhibit platelet activating factor, block leukotriene D4 receptors | PFIZER INC. (US) | 1994-06-21 | — | — | US | disclosed |
| EP-0533695-A1 | IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY. | PFIZER (US) | 1993-03-31 | — | — | EP | disclosed |
| WO-1991017163-A1 | IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY | PFIZER INC. (US) | 1991-11-14 | — | — | WO | disclosed |
| US-4504491-A | INSECTICIDE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1985-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012093-A1 | Receptor Function Regulator | GPR119, GIPR, INSR | PRSS1 2127/4885PRSS2 3290/4885PRSS3 3316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.